LDH-A Activators

he chemical class of LDH-A activators encompasses a diverse range of compounds that influence the expression or activity of lactate dehydrogenase-A (LDH-A), a key enzyme involved in lactate production through glycolysis. These activators, including Sodium Lactate, HIF-1α Stabilizers, Dichloroacetate (DCA), 2-Deoxy-D-glucose, Nicotinamide, Dimethyl sulfoxide (DMSO), Sodium Pyruvate, Insulin, Tumor Necrosis Factor-α (TNF-α), Epigallocatechin gallate (EGCG), 3-Bromopyruvate, and Resveratrol, employ various mechanisms to modulate LDH-A expression or activity.

Compounds like Sodium Lactate and Sodium Pyruvate act as substrates, increasing the availability of lactate and pyruvate, respectively, potentially facilitating their conversion by LDH-A. Hypoxia-Inducible Factor-1α (HIF-1α) stabilizers upregulate LDH-A expression in hypoxic conditions, while Dichloroacetate (DCA) inhibits pyruvate dehydrogenase kinase, promoting pyruvate conversion to acetyl-CoA and subsequently increasing LDH-A expression. Additionally, inhibitors of glycolysis such as 2-Deoxy-D-glucose and 3-Bromopyruvate enhance reliance on LDH-A for lactate production. Compounds like Nicotinamide and Insulin indirectly support LDH-A activity by influencing factors like NAD+ availability and glucose metabolism, respectively. Tumor Necrosis Factor-α (TNF-α) induces LDH-A expression through NF-κB activation in certain cell types, while EGCG and Resveratrol modulate LDH-A expression through various signaling pathways, potentially downregulating its expression.